Current concepts and occurrence of epithelial odontogenic tumors: I. Ameloblastoma and adenomatoid odontogenic tumor

Korean Journal of Pathology

Volumn 47, Issue 3, 2013, Pages 191-202

  Lee, Suk Keun ^a   Kim, Yeon Sook ^b  

^a Gangneung Wonju National University   (South Korea)

^b Chongju University   (South Korea)

Author keywords

Adenomatoid odontogenic tumor; Ameloblastoma; Craniopharyngioma

Indexed keywords

EID: 84882697079     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2013.47.3.191     Document Type: Article

References (97)

1. Sarkar L, Cobourne M, Naylor S, Smalley M, Dale T, Sharpe PT. Wnt/Shh interactions regulate ectodermal boundary formation during mammalian tooth development. Proc Natl Acad Sci U S A 2000; 97: 4520-4.
2. Thesleff I, Vaahtokari A, Kettunen P, Aberg T. Epithelial-mesenchymal signaling during tooth development. Connect Tissue Res 1995; 32: 9-15.
3. Kim JY, Kang GH, Chi JG. Adamantinoma of tibia with predominant features of fibrous dysplasia: a case report. J Korean Med Sci 1996; 11: 444-8.
4. Kato N, Endo Y, Tamura G, Motoyama T. Ameloblastoma with basal cell carcinoma-like feature emerging as a nasal polyp. Pathol Int 1999; 49: 747-51.
5. Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol 1995; 31B: 86-99.
6. Siar CH, Lau SH, Ng KH. Ameloblastoma of the jaws: a retrospective analysis of 340 cases in a Malaysian population. J Oral Maxillofac Surg 2012; 70: 608-15.
7. Dhanuthai K, Chantarangsu S, Rojanawatsirivej S, et al. Ameloblastoma: a multicentric study. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 113: 782-8.
8. Hong J, Yun PY, Chung IH, et al. Long-term follow up on recurrence of 305 ameloblastoma cases. Int J Oral Maxillofac Surg 2007; 36: 283-8.
9. Doscher JC, Kramer JM, Fantasia JE. A large calcifying lesion of the maxilla in a child. J Am Dent Assoc 2011; 142: 1026-30.
10. Lim J, Ahn H, Min S, Hong SD, Lee JI, Hong SP. Oligonucleotide microarray analysis of ameloblastoma compared with dentigerous cyst. J Oral Pathol Med 2006; 35: 278-85.
11. Snead ML, Luo W, Hsu DD, Melrose RJ, Lau EC, Stenman G. Human ameloblastoma tumors express the amelogenin gene. Oral Surg Oral Med Oral Pathol 1992; 74: 64-72.
12. Deutsch D, Fermon E, Lustmann J, et al. Tuftelin mRNA is expressed in a human ameloblastoma tumor. Connect Tissue Res 1998; 39: 177-84.
13. Lee SK, Kim SM, Lee YJ, Yamada KM, Yamada Y, Chi JG. The structure of the rat ameloblastin gene and its expression in amelogenesis. Mol Cells 2003; 15: 216-25.
14. Lee SK, Krebsbach PH, Matsuki Y, Nanci A, Yamada KM, Yamada Y. Ameloblastin expression in rat incisors and human tooth germs. Int J Dev Biol 1996; 40: 1141-50.
15. Saku T, Okabe H, Shimokawa H. Immunohistochemical demonstration of enamel proteins in odontogenic tumors. J Oral Pathol Med 1992; 21: 113-9.
16. Crivelini MM, Felipini RC, Miyahara GI, de Sousa SC. Expression of odontogenic ameloblast-associated protein, amelotin, ameloblastin, and amelogenin in odontogenic tumors: immunohistochemical analysis and pathogenetic considerations. J Oral Pathol Med 2012; 41: 272-80.
17. Al-Otaibi O, Khounganian R, Anil S, Rajendran R. Syndecan-1 (CD 138) surface expression marks cell type and differentiation in ameloblastoma, keratocystic odontogenic tumor, and dentigerous cyst. J Oral Pathol Med 2013; 42: 186-93.
18. Mishra M, Naik VV, Kale AD, Ankola AV, Pilli GS. Perlecan (basement membrane heparan sulfate proteoglycan) and its role in oral malignancies: an overview. Indian J Dent Res 2011; 22: 823-6.
19. Masloub SM, Abdel-Azim AM, Elhamid ES. CD10 and osteopontin expression in dentigerous cyst and ameloblastoma. Diagn Pathol 2011; 6: 44.
20. de Medeiros AM, Nonaka CF, Galvão HC, de Souza LB, Freitas Rde A. Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors. Eur Arch Otorhinolaryngol 2010; 267: 303-10.
21. Farias LC, Gomes CC, Rodrigues MC, et al. Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma. BMC Clin Pathol 2012; 12: 11.
22. Qian Y, Huang HZ. The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma. J Oral Pathol Med 2010; 39: 592-8.
23. Tekkesin MS, Mutlu S, Olgac V. The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas. Head Neck Pathol 2011; 5: 248-53.
24. Sengüven B, Oygür T. Investigation of interleukin-1 alpha and interleukin-6 expression and interleukin-1 alpha gene polymorphism in keratocystic odontogenic tumors and ameloblastomas. Med Oral Patol Oral Cir Bucal 2011; 16: e467-72.
25. Kumar H, Vandana R, Kumar G. Immunohistochemical expression of cyclin D1 in ameloblastomas and adenomatoid odontogenic tumors. J Oral Maxillofac Pathol 2011; 15: 283-7.
26. Scheper MA, Duarte EC, Intapa C, et al. Expression of midkine in ameloblastomas and its correlation with clinicopathologic parameters. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114: 497-502.
27. Abdel-Aziz A, Amin MM. EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence. Diagn Pathol 2012; 7: 14.
28. Sharifi-Sistani N, Zartab H, Babakoohi S, et al. Immunohistochemical comparison of the expression of p53 and MDM2 proteins in ameloblastomas and keratocystic odontogenic tumors. J Craniofac Surg 2011; 22: 1652-6.
29. Li N, Zhong M, Song M. Expression of phosphorylated mTOR and its regulatory protein is related to biological behaviors of ameloblastoma. Int J Clin Exp Pathol 2012; 5: 660-7.
30. Karathanasi V, Tosios KI, Nikitakis NG, et al. TGF-beta1, Smad-2/-3, Smad-1/-5/-8, and Smad-4 signaling factors are expressed in ameloblastomas, adenomatoid odontogenic tumors, and calcifying cystic odontogenic tumors: an immunohistochemical study. J Oral Pathol Med 2013; 42: 415-23.
31. Sukarawan W, Simmons D, Suggs C, Long K, Wright JT. WNT5A expression in ameloblastoma and its roles in regulating enamel epithelium tumorigenic behaviors. Am J Pathol 2010; 176: 461-71.
32. Sathi GA, Tsujigiwa H, Ito S, et al. Osteogenic genes related to the canonic WNT pathway are down-regulated in ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114: 771-7.
33. Ponti G, Pastorino L, Pollio A, et al. Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome. Fam Cancer 2012; 11: 411-8.
34. Park HR, Han YI, Sol MY, Lee SK. Nevoid basal cell carcinoma syndrome: report of a case. Korean J Pathol 1995; 29: 263-7.
35. Song KY, Choi YH, Kim MK, Lee KK, Ham EK. Pathological analysis of the basal cell carcinoma. Korean J Pathol 1994; 28: 160-7.
36. Alves Pereira KM, do Amaral BA, dos Santos BR, Galvão HC, Freitas Rde A, de Souza LB. Immunohistochemical expression of E-cadherin and beta-catenin in ameloblastomas and tooth germs. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 425-31.
37. Modolo F, Biz MT, de Sousa SM, Fachinelli Rde L, Crema VO. Immunohistochemical expression of Rho GTPases in ameloblastomas. J Oral Pathol Med 2012; 41: 400-7.
38. Kumamoto H, Kimi K, Ooya K. Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas. J Oral Pathol Med 2001; 30: 596-602.
39. Rizzardi C, Leocata P, Ventura L, et al. Apoptosis-related factors (TRAIL, DR4, DR5, DcR1, DcR2, apoptotic cells) and proliferative activity in ameloblastomas. Anticancer Res 2009; 29: 1137-42.
40. Shahidi S, Bronoosh P, Daneshbod Y. Follicular ameloblastoma presenting as a sinonasal tumor. Iran Red Crescent Med J 2012; 14: 113-6.
41. Castro-Silva II, Israel MS, Lima GS, de Queiroz Chaves Lourenço S. Difficulties in the diagnosis of plexiform ameloblastoma. Oral Maxillofac Surg 2012; 16: 115-8.
42. Bansal M, Chaturvedi TP, Bansal R, Kumar M. Acanthomatous ameloblastoma of anterior maxilla. J Indian Soc Pedod Prev Dent 2010;28: 209-11.
43. Ahuja A, Mathur S, Iyer VK. Acanthomatous ameloblastoma masquerading as a squamous cell carcinoma. Cytopathology 2012 Apr 25 [Epub]. http://dx.doi.org/10.1111/j.1365-2303.2012.00978.x.
44. Gupta S, Grewal H, Sah K. Granular cell ameloblastoma showing desmoplasia. Ann Saudi Med 2012; 32: 537-40.
45. Bansal A, Bhatnagar A, Saxena S. Metastasizing granular cell ameloblastoma. J Oral Maxillofac Pathol 2012; 16: 122-4.
46. Sharma VK, Verma SK, Goyal L, Chaudhary PK. Hemangiomatous ameloblastoma in maxilla: a report of a very rare case. Dent Res J (Isfahan) 2012; 9: 345-9.
47. Ide F, Shimoyama T, Horie N. Basaloid squamous cell carcinoma versus basal cell ameloblastoma. Oral Oncol 1998; 34: 154-5.
48. Saxena K, Jose M, Chatra LK, Sequiera J. Adenoid ameloblastoma with dentinoid. J Oral Maxillofac Pathol 2012; 16: 272-6.
49. Tateyama H, Tada T, Okabe M, Takahashi E, Eimoto T. Different keratin profiles in craniopharyngioma subtypes and ameloblastomas. Pathol Res Pract 2001; 197: 735-42.
50. Kim TJ, Lee YS, Kim BK, Lee KY. Ameloblastoma associated with dentinogenic ghost cell tumor: a case report. Korean J Pathol 2006; 40: 297-302.
51. Chaudhary Z, Sangwan V, Pal US, Sharma P. Unicystic ameloblastoma: a diagnostic dilemma. Natl J Maxillofac Surg 2011; 2: 89-92.
52. Gupta N, Saxena S, Rathod VC, Aggarwal P. Unicystic ameloblastoma of the mandible. J Oral Maxillofac Pathol 2011; 15: 228-31.
53. De Melo WM, Pereira-Santos D, Sonoda CK, Pereira-Freitas SA, de Moura WL, de Paulo Cravinhos JC. Large unicystic ameloblastoma of the mandible: management guided by biological behavior. J Craniofac Surg 2012; 23: e499-502.
54. Kim J, Choi IJ. Ameloblastoma arising in odontogenic cysts: report of 5 cases and its histologic characteristics. Korean J Pathol 1986; 20: 435-41.
55. Cervelli D, Marianetti TM, Boniello R, et al. Giant neglected desmoplastic ameloblastoma: reconstruction with free fibula flap. J Craniofac Surg 2012; 23: e171-4.
56. Effiom OA, Odukoya O. Desmoplastic ameloblastoma: analysis of 17 Nigerian cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 111: e27-31.
57. Bologna-Molina R, Mosqueda-Taylor A, Molina-Frechero N, Mori-Estevez AD, Sánchez-Acuña G. Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors. Med Oral Patol Oral Cir Bucal 2013; 18: e174-9.
58. Kato H, Ota Y, Sasaki M, et al. Peripheral ameloblastoma of the lower molar gingiva: a case report and immunohistochemical study. Tokai J Exp Clin Med 2012; 37: 30-4.
59. Ide F, Mishima K, Miyazaki Y, Saito I, Kusama K. Peripheral ameloblastoma in-situ: an evidential fact of surface epithelium origin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 763-7.
60. Beena VT, Choudhary K, Heera R, Rajeev R, Sivakumar R, Vidhyadharan K. Peripheral ameloblastoma: a case report and review of literature. Case Rep Dent 2012; 2012: 571509.
61. Paulus W, Stõckel C, Krauss J, Sõrensen N, Roggendorf W. Odontogenic classification of craniopharyngiomas: a clinicopathological study of 54 cases. Histopathology 1997; 30: 172-6.
62. Giangaspero F, Burger PC, Osborne DR, Stein RB. Suprasellar papillary squamous epithelioma ("papillary craniopharyngioma"). Am J Surg Pathol 1984; 8: 57-64.
63. Sekine S, Takata T, Shibata T, et al. Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation. Histopathology 2004; 45: 573-9.
64. Badger KV, Gardner DG. The relationship of adamantinomatous craniopharyngioma to ghost cell ameloblastoma of the jaws: a histopathologic and immunohistochemical study. J Oral Pathol Med 1997; 26: 349-55.
65. Zoicas F, Schõfl C. Craniopharyngioma in adults. Front Endocrinol (Lausanne) 2012; 3: 46.
66. Rodriguez FJ, Scheithauer BW, Tsunoda S, Kovacs K, Vidal S, Piepgras DG. The spectrum of malignancy in craniopharyngioma. Am J Surg Pathol 2007; 31: 1020-8.
67. Horváth A, Horváth E, Popşor S. Mandibular ameloblastic carcinoma in a young patient. Rom J Morphol Embryol 2012; 53: 179-83.
68. Casaroto AR, Toledo GL, Filho JL, Soares CT, Capelari MM, Lara VS. Ameloblastic carcinoma, primary type: case report, immunohistochemical analysis and literature review. Anticancer Res 2012; 32: 1515-25.
69. Bedi RS, Chugh A, Pasricha N. Ameloblastic carcinoma of maxilla. Natl J Maxillofac Surg 2012; 3: 70-4.
70. Yoon HJ, Hong SP, Lee JI, Lee SS, Hong SD. Ameloblastic carcinoma: an analysis of 6 cases with review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 904-13.
71. Pundir S, Saxena S, Rathod V, Aggrawal P. Ameloblastic carcinoma: secondary dedifferentiated carcinoma of the mandible: report of a rare entity with a brief review. J Oral Maxillofac Pathol 2011; 15: 201-4.
72. Fujita S, Anami M, Satoh N, et al. Cytopathologic features of secondary peripheral ameloblastic carcinoma: a case report. Diagn Cytopathol 2011; 39: 354-8.
73. Kawauchi S, Hayatsu Y, Takahashi M, et al. Spindle-cell ameloblastic carcinoma: a case report with immunohistochemical, ultrastructural, and comparative genomic hybridization analyses. Oncol Rep 2003; 10: 31-4.
74. Khojasteh A, Khodayari A, Rahimi F, et al. Hypermethylation of p16 tumor-suppressor gene in ameloblastic carcinoma, ameloblastoma, and dental follicles. J Oral Maxillofac Surg 2013; 71: 62-5.
75. Slootweg PJ, Müller H. Malignant ameloblastoma or ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol 1984; 57: 168-76.
76. Dissanayake RK, Jayasooriya PR, Siriwardena DJ, Tilakaratne WM. Review of metastasizing (malignant) ameloblastoma (METAM): pattern of metastasis and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 111: 734-41.
77. Lai H, Wang J. Benign metastasizing ameloblastoma or malignant ameloblastoma?. J Craniofac Surg 2011; 22: 995-7.
78. Baskaran P, Misra S, Kumar MS, Mithra R. Adenomatoid odontogenic tumor: a report of two cases with histopathology correlation. J Clin Imaging Sci 2011; 1: 64.
79. Vasudevan K, Kumar S, Vijayasamundeeswari, Vigneswari S. Adenomatoid odontogenic tumor, an uncommon tumor. Contemp Clin Dent 2012; 3: 245-7.
80. Sharma N, Passi S, Kumar VV. Adenomatoid odontogenic tumor: as an unusual mandibular manifestation. Contemp Clin Dent 2012; 3(Suppl 1): S29-32.
81. de Matos FR, Nonaka CF, Pinto LP, de Souza LB, de Almeida Freitas R. Adenomatoid odontogenic tumor: retrospective study of 15 cases with emphasis on histopathologic features. Head Neck Pathol 2012; 6: 430-7.
82. Chindasombatjaroen J, Poomsawat S, Kakimoto N, Shimamoto H. Calcifying cystic odontogenic tumor and adenomatoid odontogenic tumor: radiographic evaluation. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114: 796-803.
83. Becker T, Buchner A, Kaffe I. Critical evaluation of the radiological and clinical features of adenomatoid odontogenic tumour. Dentomaxillofac Radiol 2012; 41: 533-40.
84. Handschel JG, Depprich RA, Zimmermann AC, Braunstein S, Kübler NR. Adenomatoid odontogenic tumor of the mandible: review of the literature and report of a rare case. Head Face Med 2005; 1: 3.
85. Razavi SM, Tabatabaie SH, Hoseini AT, Hoseini ET, Khabazian A. A comparative immunohistochemical study of Ki-67 and Bcl-2 expression in solid ameloblastoma and adenomatoid odontogenic tumor. Dent Res J (Isfahan) 2012; 9: 192-7.
86. Salehinejad J, Zare-Mahmoodabadi R, Saghafi S, et al. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor. J Oral Sci 2011; 53: 213-7.
87. Krishna A, Kaveri H, Naveen Kumar RK, Kumaraswamy KL, Shylaja S, Murthy S. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor. J Cancer Res Ther 2012; 8: 232-7.
88. Harnet JC, Pedeutour F, Raybaud H, Ambrosetti D, Fabas T, Lombardi T. Immunohistological features in adenomatoid odontogenic tumor: review of the literature and first expression and mutational analysis of beta-catenin in this unusual lesion of the jaws. J Oral Maxillofac Surg 2013; 71: 706-13.
89. Tsuneki M, Maruyama S, Yamazaki M, Cheng J, Saku T. Podoplanin expression profiles characteristic of odontogenic tumor-specific tissue architectures. Pathol Res Pract 2012; 208: 140-6.
90. Poomsawat S, Punyasingh J, Vejchapipat P, Larbcharoensub N. Co-expression of hepatocyte growth factor and c-met in epithelial odontogenic tumors. Acta Histochem 2012; 114: 400-5.
91. Philipsen HP, Samman N, Ormiston IW, Wu PC, Reichart PA. Variants of the adenomatoid odontogenic tumor with a note on tumor origin. J Oral Pathol Med 1992; 21: 348-52.
92. Philipsen HP, Reichart PA, Zhang KH, Nikai H, Yu QX. Adenomatoid odontogenic tumor: biologic profile based on 499 cases. J Oral Pathol Med 1991; 20: 149-58.
93. Jivan V, Altini M, Meer S, Mahomed F. Adenomatoid odontogenic tumor (AOT) originating in a unicystic ameloblastoma: a case report. Head Neck Pathol 2007; 1: 146-9.
94. Prasad G, Nair P, Thomas S, Gharote H, Singh N, Bhambal A. Extrafollicular adenomatoid odontogenic tumour. BMJ Case Rep 2011; 2011. http://dx.doi.org/10.1136/bcr.03.2011.3963.
95. Avinash Tejasvi ML, Prashanth Shenai K, Chatra L. Atypical case of periapical adenomatoid odontogenic tumour. J Maxillofac Oral Surg 2010; 9: 99-101.
96. Ide F, Mishima K, Saito I, Kusama K. Rare peripheral odontogenic tumors: report of 5 cases and comprehensive review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106: e22-8.
97. Sandhu SV, Narang RS, Jawanda M, Rai S. Adenomatoid odontogenic tumor associated with dentigerous cyst of the maxillary antrum: a rare entity. J Oral Maxillofac Pathol 2010; 14: 24-8.